| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/15/2006 | EP1625202A2 Novel lipolytic enzyme lip1 |
| 02/15/2006 | EP1625201A2 Production of carotenoids in microorganisms |
| 02/15/2006 | EP1625160A1 A bioelastomer |
| 02/15/2006 | EP1625142A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 02/15/2006 | EP1625141A2 Grp94-based compositions and methods of use thereof |
| 02/15/2006 | EP1625140A2 Branched immunomodulatory compounds and methods of using the same |
| 02/15/2006 | EP1625138A2 Protected monomers |
| 02/15/2006 | EP1624788A2 Use of endo180 receptor for diagnosis and treatment of disease |
| 02/15/2006 | EP1481057B1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 02/15/2006 | EP1080099B1 Method and device for purifying nucleic acids |
| 02/15/2006 | EP0762892B1 Diphtheria toxin vaccines bearing a mutated r domain |
| 02/15/2006 | CN1735693A Method for in vitro selection of 2'-substituted nucleic acids |
| 02/15/2006 | CN1735687A MK2 interacting proteins |
| 02/15/2006 | CN1735684A P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 02/15/2006 | CN1735433A Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 02/15/2006 | CN1733916A siRNA for suppressing Stat3 gene expression and its preparation method |
| 02/15/2006 | CN1733791A Extraction and purification method of general DNA of compost microbe |
| 02/15/2006 | CN1733790A Method for extracting RNA from wheat mitochondria |
| 02/15/2006 | CN1242061C Short finger gene |
| 02/15/2006 | CN1241946C Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 02/15/2006 | CN1241933C Plasmid DNA purifying method by phase separation method |
| 02/14/2006 | US6998478 The promoter controls specific gene expression at the transcriptional level in cotton fibers so may be used in improving cotton fibers to create new cotton varieties with high fiber quality and yield by gene manipulation. |
| 02/14/2006 | US6998474 used for prevention and/or treatment of pathologies, dysfunctions, disorders or conditions affecting the nervous system |
| 02/14/2006 | US6998472 Obesity gene |
| 02/14/2006 | US6998471 Plant extract; hybrid nucleic acids; genetic engineering; polymerase chain reactions cycles |
| 02/14/2006 | US6998268 Gene preparations |
| 02/14/2006 | US6998253 polypeptide of interest is cleared from kidney and does not contain a Fc region of an IgG, which variant comprises a salvage receptor binding epitope of an Fc region of an IgG, and which variant has a longer in vivo half-life than the polypeptide |
| 02/14/2006 | US6998239 contacting an isolated or recombinant CCX CKR polypeptide or, a fragment or variant, and the chemokine in the presence of a test compound, comparing the level of binding of the chemokine and the polypeptide |
| 02/14/2006 | US6998232 determining, in a sample from a human subject, the level of expression of at least two polynucleotides, wherein a higher level of expression of the polynucleotides compared to cancer free human polynucleotide expression is an indication of cancer |
| 02/14/2006 | US6998231 Coding or classification of prion sample; obtain sample, monitor physical properties of sample, compare to control |
| 02/14/2006 | US6998229 Used to control expression of a transgene, detect glucuronides in a sample, and isolate glucuronides from a sample |
| 02/14/2006 | US6998122 which retain wild-type biological activity and extend half-lives in human blood; resistant to serpin activation; for treatment of vascular occlusive disorders, hypercoagulable states, and thrombotic disorders |
| 02/14/2006 | CA2306762C Synthesis of polynucleotides having random sequences |
| 02/14/2006 | CA2269072C Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/14/2006 | CA2247889C Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 02/09/2006 | WO2006015057A2 C-terminally truncated interferon |
| 02/09/2006 | WO2006014588A2 Nucleic acid end-labeling reagents |
| 02/09/2006 | WO2005118864A3 Antibodies and related molecules that bind to psca proteins |
| 02/09/2006 | WO2005108617A3 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 02/09/2006 | WO2005103302A3 Mutant viral nucleic acids and vaccine containing same |
| 02/09/2006 | WO2005086896A3 Delivery vectors for short interfering rna, micro-rna and antisense rna |
| 02/09/2006 | WO2005074647A3 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 02/09/2006 | WO2005067643A3 Determination of hepatitis c virus genotype |
| 02/09/2006 | WO2005017188A3 Fusion proteins with a membrane translocating sequence and methods of using same to inhibit an immune response |
| 02/09/2006 | US20060031968 Isolated plant deoxyhypusine synthase and nucleotides encoding same |
| 02/09/2006 | US20060031967 Compositions and methods for modulation of plant cell division |
| 02/09/2006 | US20060031963 Method for the production of ketocarotinoids in flower petals on plants |
| 02/09/2006 | US20060031962 Antifungal polypeptides |
| 02/09/2006 | US20060031961 Aldehyde reductase |
| 02/09/2006 | US20060031959 Nucleic acid fragments encoding proteins involved in stress response |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060031949 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060031948 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060031947 Novel mutated mammalian cells and animals |
| 02/09/2006 | US20060031945 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060030698 Nucleic acid molecules and other molecules associated with plants |
| 02/09/2006 | US20060030541 Genes involved in osteogenesis, and methods of use |
| 02/09/2006 | US20060030537 Ceramide kinase and uses thereof |
| 02/09/2006 | US20060030527 Rage fusion proteins and methods of use |
| 02/09/2006 | US20060030045 Antisense modulation of c/ebp beta expression |
| 02/09/2006 | US20060030019 HDAC9 polypeptides and polynucleotides and uses thereof |
| 02/09/2006 | US20060030015 Novel process for producing antibody enzyme, novel antibody enzyme and utilization thereof |
| 02/09/2006 | US20060030011 Polynucleotides encoding polypeptides involved in the stress response to environmental changes in Methylophilus methylotrophus |
| 02/09/2006 | US20060030010 Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in Methylophilus methylotrophus |
| 02/09/2006 | US20060030008 kit for purifying a recombinant fusion protein containing a DNA expression vector plasmid having a sequence encoding a mutant chitin-binding domain capable of reversible binding under non-denaturing conditions |
| 02/09/2006 | US20060030007 Peptides for metal ion affinity chromatography |
| 02/09/2006 | US20060030006 Identification of a conserved region of plasmodium falciparum MSP3 targeted by biologically active antibodies |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060030004 Solid phase synthesis |
| 02/09/2006 | US20060030003 Composition and method for introduction of RNA interference sequences into targeted cells and tissues |
| 02/09/2006 | US20060030002 Isoforms of the human Vitamin D receptor |
| 02/09/2006 | US20060030001 Useful polypeptides |
| 02/09/2006 | US20060030000 Growth factor binding constructs materials and methods |
| 02/09/2006 | US20060029999 Nucleic acid sequences having an activity of regulating translation efficiency and utilization thereof |
| 02/09/2006 | US20060029998 Codes with nucleic acids; antiinflammatory agents; immunomodulation |
| 02/09/2006 | US20060029997 nucleic acid sequence encoding an adhesive protein derived from a mollusk foot protein(MEFP-1); waterproof adhesives |
| 02/09/2006 | US20060029996 CDNA, or expression vector comprising the nucleotide sequence linked to an expression control sequence; biosynthesis of waterproof bioadhesive proteins, adhesins; high strength, durability |
| 02/09/2006 | US20060029975 Mixture comprising short tandem duplicated sequences for use as tool in screening and characterizing preferential preferential DNA sample |
| 02/09/2006 | US20060029972 Method for nucleic acid extraction and nucleic acid purification |
| 02/09/2006 | US20060029968 Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids |
| 02/09/2006 | US20060029966 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/09/2006 | US20060029963 Isolated from Bacillus substilus; solid phase synthesis; reverse transcription; immunogens; transfected cells |
| 02/09/2006 | US20060029945 Novel full length cDNA |
| 02/09/2006 | US20060029944 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
| 02/09/2006 | US20060029940 Prostate stem cell antigen (PSCA) variants and subsequences thereof |
| 02/09/2006 | US20060029939 Decomposition and modification of silicate and silicone by silase and use of the reversible enzyme |
| 02/09/2006 | US20060029936 UV excitable energy transfer reagents |
| 02/09/2006 | US20060029933 For near real-time detection of environmental and terrorist agents including cryptosporidium and giardia, which contaminate public water supplies, and ricin, anthrax and ebola virus, bio-terrorism and bio-warfare; nanoelectronics, nanofabrication and nanomachines; chemical screening |
| 02/09/2006 | US20060029931 Small, interfering RNA (siRNA) molecules which inhibit expression of HALP (HIV-Associated Life Preserver) protein cloned into a plasmid or retroviral vector for introduction into host cells; screening HIV-modulating componds which prevent apoptosis resistance of infected cell; gene therapy |
| 02/09/2006 | US20060029928 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a |
| 02/09/2006 | US20060029611 Prevention and treatment of amyloidogenic disease |
| 02/09/2006 | US20060029610 GRP94-based compositions and methods of use thereof |
| 02/09/2006 | US20060029604 Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform |
| 02/09/2006 | US20060029602 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 02/09/2006 | CA2575500A1 Monocot ahass sequences and methods of use |
| 02/09/2006 | CA2574917A1 Capture probe design for efficient hybridisation |
| 02/09/2006 | CA2574496A1 Methods for diagnosis using anti-cytokine receptor antibodies |
| 02/08/2006 | EP1624068A1 Genetic immunization with cationic lipids |
| 02/08/2006 | EP1624059A2 Method of producing nucleic acid molecules with reduced secondary structure |
| 02/08/2006 | EP1623046A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |